News
Acquired animal cloning company Viagen
Company Context
- Company Value
- $10.2B
- Revenue
- $55.6M estimated annual revenue (Growjo, Mar 2026)
- Market
- Biotech
- Stage
- Growth
Key Highlight
Announced the controversial "de-extinction" of the dire wolf in April 2025, generating significant media attention and scientific debate.
More from Colossal
More Biotech News
- MinicircleKlotho Gene Therapy launching in 2026Mar 2026
- AetherRaised $15M to reindustrialize America with AI-designed proteinsDec 2025
- Latus BioAnnounced IND Clearance of LTS-101 for CLN2 DiseaseDec 2025
- Latus BioLaunched AI/ML Strategy to Transform AAV Gene TherapyNov 2025
- MENTEN AIAndrea McNeal joined as VP of Business DevelopmentOct 2025